# US 2022/0031518 A1 · Foot patch

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031518 A1
- Document ID: US20220031518A1
- Status: Published application
- Kind: A1
- Application number: 16/983,738
- Filed: 2020-08-03
- Published: 2022-02-03
- Earliest claimed: 2020-08-03
- Assignees: Everyday Alchemy, LLC
- Applicants: Everyday Alchemy, LLC
- Inventors: Austin KATZ
- Web page: https://patentgrep.com/patent/US20220031518A1

## CPC

- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61F 13/067: {for the sole of the foot (rigid shoe insertions for supporting the sole A61F5/14)}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/7023: {Transdermal patches and similar drug-containing composite devices, e.g. cataplasms (galenical aspects of iontophoretic devices A61K9/0009; microneedle arrays A61K9/0021; buccal patches A61K9/006)}
- A61K 9/703: {characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches}
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/3482: {Cannabis}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A foot patch is described herein where the foot patch is configured for placement upon a sole of a foot for sustained delivery of one or more agents. The patch may generally comprise a distal patch body and an elongated proximal portion positioned to project from one end of the distal portion. A proximal patch body may also be included for placement upon a heel of the sole of the foot. The patches may be infused with one or more agents including CBD, arnica oil, and menthol for transdermal delivery into the sole when the patches are adhered to the sole for a period of time.

## Claims

### Claim 1

A transdermal patch configured for placement upon a sole of a foot for sustained delivery of one or more agents, comprising:
a distal patch body defining a contact surface for securement to the sole and having a distal portion and an elongated proximal portion positioned to project from one end of the distal portion,
wherein the distal portion defines a curved distal border configured for placement proximal to one or more toes of the foot and a curved proximal border configured to extend along or over an anterior transverse arch of the sole such that the distal portion is configured to span a transverse arch of the sole when adhered via the contact surface,
wherein the elongated proximal portion defines a length which is configured to extend proximally along and to cover a lateral longitudinal arch of the sole when adhered via the contact surface, and
wherein the distal patch body is infused with the one or more agents including CBD, arnica oil, and menthol for transdermal delivery into the sole when the distal patch body is adhered to the sole for a period of time.

### Claim 2 (depends on 1)

The transdermal patch of claim 1 further comprising a proximal patch body separate from the distal patch body and sized for placement upon a heel of the sole.

### Claim 3 (depends on 2)

The transdermal patch of claim 2 wherein the proximal patch body is configured into a circular shape.

### Claim 4 (depends on 1)

The transdermal patch of claim 1 wherein the distal patch body is comprised of a fabric having 95% cotton and 5% polyester.

### Claim 5 (depends on 1)

The transdermal patch of claim 1 wherein the one or more agents further includes Helianthus annuus (sunflower) seed oil.

### Claim 6 (depends on 1)

The transdermal patch of claim 1 wherein the CBD is comprised of 99% Cannabis sativa seed oil hemp oil.

### Claim 7 (depends on 1)

The transdermal patch of claim 1 wherein the one or more agents comprise 10 mg of CBD, 4 mg of arnica oil, and 6 mg of menthol.

### Claim 8

A transdermal patch assembly, comprising:
a first proximal patch body sized for placement upon a first heel of a first sole of a first foot;
a first distal patch body separate from the proximal patch body and defining a contact surface for securement to the first sole of the first foot and having a distal portion and an elongated proximal portion positioned to project from one end of the distal portion,
wherein the distal portion defines a curved distal border configured for placement proximal to one or more toes of the first foot and a curved proximal border configured to extend along or over an anterior transverse arch of the first sole such that the distal portion is configured to span a transverse arch of the first sole when adhered via the contact surface,
wherein the elongated proximal portion defines a length which is configured to extend proximally along and to cover a lateral longitudinal arch of the first sole when adhered via the contact surface, and
wherein the first proximal patch body and first distal patch body are infused with one or more agents including CBD, arnica oil, and menthol for transdermal delivery into the first sole when the distal patch body is adhered to the first sole for a period of time.

### Claim 9 (depends on 8)

The transdermal patch assembly of claim 8 further comprising a second proximal patch body sized for placement upon a second heel of a second sole of a second foot and a second distal patch body separate from the second proximal patch body and defining a contact surface for securement to the second sole of the second foot.

### Claim 10 (depends on 8)

The transdermal patch assembly of claim 8 wherein the first proximal patch body and first distal patch body are comprised of a fabric having 95% cotton and 5% polyester.

### Claim 11 (depends on 8)

The transdermal patch assembly of claim 8 wherein the one or more agents further includes Helianthus annuus (sunflower) seed oil.

### Claim 12 (depends on 8)

The transdermal patch assembly of claim 8 wherein the CBD is comprised of 99% Cannabis sativa seed oil hemp oil.

### Claim 13 (depends on 8)

The transdermal patch assembly of claim 8 wherein the one or more agents comprise 20 mg of CBD, 8 mg of arnica oil, and 12 mg of menthol.

### Claim 14

A method of treating a foot of a subject, comprising:
applying a distal patch body via a contact surface upon a sole of the foot such that a curved distal border of a distal portion is adhered proximal to one or more toes of the foot and a curved proximal border of the distal portion is adhered to extend along or over an anterior transverse arch of the sole such that the distal portion spans a transverse arch of the sole;
further applying the distal patch body such that an elongated proximal portion projecting from one end of the distal portion is adhered to cover a lateral longitudinal arch of the sole; and
maintaining the distal patch body upon the sole of the foot for a period of time such that one or more agents including CBD, arnica oil, and menthol which are infused into the distal patch body are delivered transdermally into the sole.

### Claim 15 (depends on 14)

The method of claim 14 further comprising applying a proximal patch body via a contact surface upon a heel of the sole, wherein the proximal patch body is separate from the distal patch body.

### Claim 16 (depends on 15)

The method of claim 15 further comprising maintaining the proximal patch body upon the heel for a period of time such that the one or more agents which are infused into the proximal patch body are delivered transdermally into the heel.

### Claim 17 (depends on 15)

The method of claim 15 further comprising applying a second distal patch body defining a second contact surface upon a second sole of a second foot.

### Claim 18 (depends on 17)

The method of claim 17 further comprising applying a second proximal patch body via a second contact surface upon a second heel of the second foot, wherein the second proximal patch body is separate from the second distal patch body.

### Claim 19 (depends on 14)

The method of claim 14 wherein maintaining the distal patch body comprises maintaining the distal patch body for up to an eight-hour period of time.

### Claim 20 (depends on 14)

The method of claim 14 further comprising removing a film from the contact surface prior to applying the distal patch body.
